Article
Knockdown of KLK11 reverses oxaliplatin resistance by inhibiting proliferation and…
OncoTargets and Therapy · 2018 · Zhang Y, Xu Z, Sun Y, Chi P, Lu X
Key facts
| Title | Knockdown of KLK11 reverses oxaliplatin resistance by inhibiting proliferation and activating apoptosis via suppressing the PI3K/AKT signal pathway in colorectal cancer cell |
|---|---|
| First author | Zhang Y, Xu Z, Sun Y, Chi P, Lu X |
| Journal | OncoTargets and Therapy |
| Published | Feb 16, 2018 |
| DOI | 10.2147/OTT.S151867 |
| Devices mentioned | 011635 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1